Cita APA

Pignolet, B., Rio Izquierdo, J., Vermersch, P., deSèze, J., Montalban Gairín, X., Comabella Lopez, M., . . . Ruet, A. (2021). Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab.

Citación estilo Chicago

Pignolet, Beatrice, Jordi Rio Izquierdo, Patrick Vermersch, Jerome deSèze, Xavier Montalban Gairín, Manuel Comabella Lopez, Nicolás Miguel Fissolo, y Aurélie Ruet. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. 2021.

Cita MLA

Pignolet, Beatrice, et al. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. 2021.